Screening for anti-methicillin resistant Staphylococcus aureus (MRSA) bacteriocin producing bacteria

Abstract

Methicillin resistant bacterial infections give a tough challenge in the selection of antibiotics. Traditional use of antibiotics is worsening the problem day by day. So, it is essential to sort out other strategies which can replace antibiotic therapy successfully. Bacteriocins are the proteinaceous compounds with a narrower spectrum of antimicrobial activity but its use as antibiotic is not common. No one has ever tried to use it for the treatment of infections. Presently, we have isolated bacteriocin producing bacteria effective against methicillin resistant bacteria. It will help in controlling MRSA infections as well as provide a new strategy to treat reemerging infections.